Actively Recruiting
The Seaver Autism Center for Research and Treatment - Assessment Core Characterizing ADNP-Related Neurodevelopmental Disorders Using Genetic and Neuropsychological Measures
Led by Icahn School of Medicine at Mount Sinai · Updated on 2025-05-09
30
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
I
Icahn School of Medicine at Mount Sinai
Lead Sponsor
T
The Seaver Foundation
Collaborating Sponsor
AI-Summary
What this Trial Is About
ADNP syndrome, also known as Activity Dependent Neuroprotective Protein syndrome, is a rare neurodevelopmental disorder caused by mutations in the ADNP gene on chromosome 20. It is characterized by intellectual disability and global developmental delay. This observational study aims to better understand ADNP-related neurodevelopmental disorders by using various genetic, medical, and neuropsychological assessments to describe the condition comprehensively. Participants who have a confirmed variant in the ADNP gene will undergo multiple developmental, behavioral, and medical evaluations over a three-day period. Assessments include the Autism Diagnostic Observation Schedule (ADOS), parent interviews about developmental history and behavior, psychiatric and neurology evaluations, and a clinical genetic exam with physical and vital sign checks. Additionally, affected individuals and their biologically related siblings will complete sensory tests such as research EEG, visual evoked potential, and eyetracking assessments. Family members present may also be asked to provide blood or saliva samples for genetic research. During the study, participants will be involved in detailed testing including standardized intelligence scales and diagnostic interviews to measure cognitive and behavioral features. Researchers will collect data through interviews, clinical exams, and sensory tests to characterize the neurodevelopmental profile associated with ADNP variants. The primary outcome is the Autism Diagnostic Observation Schedule, with several secondary outcome measures assessing intellectual abilities. The study is led by the Icahn School of Medicine at Mount Sinai and has no maximum age limit for participation.
CONDITIONS
Brief Title
ADNP Syndrome: The Seaver Autism Center for Research and Treatment is Characterizing ADNP-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Have a documented variant affecting the ADNP gene that is likely or definitely pathogenic
- Be at least 2 years of age
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 3 days
Participants complete a series of developmental, behavioral, and medical assessments to characterize gene-related neurodevelopmental deficits. This includes the Autism Diagnostic Observation Schedule, parent interviews, psychiatric and neurology evaluations, clinical genetic evaluation, sensory assessments such as EEG, visual evoked potential, and eyetracking, and collection of blood and/or saliva samples from family members for research genetics.
1 visit (in-person)
Trial Site Locations
Total: 1 location
1
The Seaver Autism Center for Research and Treatment
New York, New York, United States, 10029
Actively Recruiting
Research Team
T
Tess Levy
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here